Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis

被引：21

作者：

Fowler, Emilie ^{[1
,2
]}

Rosen, Jordan ^{[1
,2
]}

Lev-Tov, Hadar ^{[1
]}

Yosipovitch, Gil ^{[1
,2
]}

机构：

[1] Univ Miami, Miller Sch Med, Dr Phillip Frost Dept Dermatol & Cutaneous Surg, 1600 NW 10th Ave,RMSB 2067B, Miami, FL USA

[2] Univ Miami, Miller Sch Med, Miami Itch Ctr, 1600 NW 10th Ave,RMSB 2067B, Miami, FL USA

来源：

ACTA DERMATO-VENEREOLOGICA | 2019年 / 99卷 / 10期

关键词：

CYCLOSPORINE; RISK;

D O I：

10.2340/00015555-3201

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：899 / 900

页数：2

共 5 条

[1] Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review [J].

Braddock, Martin ;

Hanania, Nicola A. ;

Sharafkhaneh, Amir ;

Colice, Gene ;

Carlsson, Mats .

DRUG SAFETY, 2018, 41 (05) :489-509

[2] Azathioprine and risk of multiple keratinocyte cancers [J].

Cho, Hyunje G. ;

Kuo, Karen Y. ;

Xiao, Katherine ;

Batra, Prag ;

Li, Shufeng ;

Tang, Jean Y. ;

Sarin, Kavita Y. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (01) :27-+

[3] Dupilumab: A review of its use in the treatment of atopic dermatitis [J].

Gooderham, Melinda J. ;

Hong, H. Chih-ho ;

Eshtiaghi, Panteha ;

Papp, Kim A. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (03) :S28-S36

[4] Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study [J].

Paul, CF ;

Ho, VC ;

McGeown, C ;

Christophers, E ;

Schmidtmann, B ;

Guillaume, JC ;

Lamarque, V ;

Dubertret, L .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (02) :211-216

[5] Non-Hodgkin's lymphoma following treatment of atopic eczema with cyclosporin A [J].

Sinha, A ;

Velangi, S ;

Natarajan, S .

ACTA DERMATO-VENEREOLOGICA, 2004, 84 (04) :327-328

← 1 →